Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Safety and tolerance of recombinant interferon alfa‐2a (roferon®‐A) in Cancer PatientsJones, Gary J. ; Itri, Loretta M.Cancer, 1986-04, Vol.57 (S8), p.1709-1715 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa‐2a by intramuscular injectionItri, Loretta M. ; Campion, Marilyn ; Dennin, Robert A. ; Palleroni, Alicia V. ; Gutterman, Jordan U. ; Groopman, Jerome E. ; Trown, Patrick W.Cancer, 1987-02, Vol.59 (S3), p.668-674 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
3 |
Material Type: Artigo
|
THE INTERFERONSITRI, LMCancer, 1992-08, Vol.70 (4), p.940-945 [Periódico revisado por pares]NEW YORK: WileyTexto completo disponível |
|
4 |
Material Type: Artigo
|
Cancer chemopreventionItri, Loretta M.Cancer, 1993-12, Vol.72 (S11), p.3374-3380 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
5 |
Material Type: Artigo
|
Recombinant leukocyte a interferon (rIFN‐αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long‐term responding patientsCreagan, Edward T. ; Ahmann, David L. ; Frytak, Stephen ; Long, Harry J. ; Itri, Loretta M.Cancer, 1986-12, Vol.58 (12), p.2576-2578 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non‐small cell lung cancerItri, Loretta M. ; Gralla, Richard J. ; Kelsen, David P. ; Chapman, Robert A. ; Casper, Ephraim S. ; Braun, David W. ; Howard, Jane E. ; Golbey, Robert ; Heelan, Robert T.Cancer, 1983-03, Vol.51 (6), p.1050-1055 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
7 |
Material Type: Artigo
|
Three consecutive phase II studies of recombinant interferon alfa–2a in advanced malignant melanoma. Updated analysesCreagan, Edward T. ; Ahmann, David L. ; Frytak, Stephen ; Long, Harry J. ; Chang, M. N. ; Itri, Loretta M.Cancer, 1987-02, Vol.59 (S3), p.638-646 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
8 |
Material Type: Artigo
|
Second primary tumors in patients with head and neck squamous cell carcinomaJones, Andrew S. ; Morar, Pradeep ; Phillips, David E. ; Field, John K. ; Husband, David ; Helliwell, Timothy R.Cancer, 1995-03, Vol.75 (6), p.1343-1353 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
9 |
Material Type: Artigo
|
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDaliani, Danai D. ; Papandreou, Christos N. ; Thall, Peter F. ; Wang, Xuemei ; Perez, Cherie ; Oliva, Rose ; Pagliaro, Lance ; Amato, RobertCancer, 2002-08, Vol.95 (4), p.758-765 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
10 |
Material Type: Artigo
|
Interferon‐alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon‐alpha‐2A in an adjuvant multicenter trialPrümmer, OttoCancer, 1993-03, Vol.71 (5), p.1828-1834 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |